Back to Search
Kimidess
by Endo Operations LtdContraceptionCOCP
DiscontinuedGeneric

Estrogen

Ethinyl Estradiol

0.02Mg,0.01Mg

Progestin

Desogestrel

0.15Mg

Regimen Protocol

Biphasic Shortened hormone-free interval (28-day cycle with <7 placebo days)

Androgenicity

Low/Reduced Androgenic

Approval Date

4/30/2015

Additives
None
Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Mayne Pharma Inc.

Azurette

Lupin Ltd

Bekyree

Naari Pte Ltd

Desogestrel And Ethinyl Estradiol

Xiromed Llc

Desogestrel And Ethinyl Estradiol

Teva Pharmaceuticals USA, Inc.

Kariva

Northstar Rx LLC

Pimtrea

Aurobindo Pharma Limited

Simliya

Glenmark Pharmaceuticals Inc., USA

Viorele

Xiromed, LLC.

Volnea

Have clinical questions about Kimidess?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy